SICEM 2023

Breakfast symposium 1 [BI-LLY] & [Yuhan] Day 3, Saturday, October 28, 07:30-08:00 / Room 1 (3F)

Chairpersons : Ho-Sang Shon (Raphael Hospital, Korea), Tae Keun Oh (Chungbuk National University, Korea)

	07:30-07:45	Treatment of type 2 diabetic patients with empagliflozin, considering heart failure Jae-Han Jeon (Kyungpook National University, Korea)
	07:45-08:00	The future role of DPP-4 inhibitor in patients with type 2 diabetes Jang Won Son (The Catholic University of Korea, Korea)

Breakfast symposium 2 [Chong Kun Dang Pharm] & [Viatris] Day 3, Saturday, October 28, 07:30-08:00 / Room 2 (3F)

Chairpersons : Donghyeok Cho (Chonnam National University, Korea), Hae Jin Kim (Ajou University, Korea)

	07:30-07:45	Efficacy and safety of thiazolidinedione and DPP-4 inhibitor combination therapy Hwiseung Kim (Chung-Ang University, Korea)
	07:45-08:00	Statin for the CV prevention in DM patients focusing on 3 points: guidelines, evidences, and differences Shinae Kang (Yonsei University, Korea)

Breakfast symposium 3 [Boryung] & [HK inno.N] Day 3, Saturday, October 28, 07:30-08:00 / Room 3 (3F)

Chairpersons : Seongbin Hong (Inha University, Korea), Hyeong-Kyu Park (Soonchunhyang University, Korea)

	07:30-07:45	Thiazolidinedione and SGLT2 inhibitor: a rational combination based on type 2 diabetes pathophysiology Sang Yong Kim (Chosun University, Korea)
	07:45-08:00	Sarpogrelate: PAD symptom improvement for diabetic patient Hyuk-Sang Kwon (The Catholic University of Korea, Korea)

Luncheon symposium 1 [Chong Kun Dang Pharm] & [Amgen] Day 2, Friday, October 27, 12:10-12:40 / Room 1 (3F)

Chairpersons : Hong Kyu Lee (Seoul National University, Korea), Hyun Koo Yoon (CHEIL-CLINIC, Korea)

	12:10-12:25	Cardio-renal benefit of SGLT2 inhibitor in type 2 diabetes & combination therapy with thiazolidinedione Mihae Seo (Soonchunhyang University, Korea)
	12:25-12:40	How to forge a path forward for strengthening bone health Beom-Jun Kim (University of Ulsan, Korea)

Luncheon symposium 2 [LG Chem] & [Novo Nordisk] Day 2, Friday, October 27, 12:10-12:40 / Room 2 (3F)

Chairpersons : Ho-Young Son (The Catholic University of Korea, Korea), Moon-Kyu Lee (Eulji University, Korea)

	12:10-12:25	Combination strategy of DPP-4 inhibitor & SGLT2 inhibitor aligned with the recently updated guidelines Hye Jin Yoo (Korea University, Korea)
	12:25-12:40	Latest evidences on patients benefit from initiation of IDegLira on prior injectable therapy Yeoree Yang (The Catholic University of Korea, Korea)

Luncheon symposium 3 [Handok] & [BI-LLY] Day 2, Friday, October 27, 12:10-12:40 / Room 3 (3F)

Chairpersons : Sung Koo Kang (The Catholic University of Korea, Korea), Seong Yeon Kim (Seoul National University, Korea)

	12:10-12:25	Pleiotropic effects of Suglat® in metabolic syndrome of type 2 diabetic patients Sunghwan Suh (Sungkyunkwan University, Korea)
	12:25-12:40	Empagliflozin, treatment of type 2 diabetic patients considering renal function Nam Hoon Kim (Korea University, Korea)

Luncheon symposium 4 [Dong-A ST] & [Yuhan] Day 3, Saturday, October 28, 12:40-13:10 / Room 1 (3F)

Chairpersons : Chulsik Kim (Yonsei University, Korea), Keeho Song (Konkuk University, Korea)

	12:40-12:55	What's new in drug treatment of diabetes Yun Kyung Cho (University of Ulsan, Korea)
	12:55-13:10	The harmony for holistic treatment of type 2 diabetes Jun Hwa Hong (Eulji University, Korea)

Luncheon symposium 5 [MSD] & [JW Pharmaceutical] Day 3, Saturday, October 28, 12:40-13:10 / Room 2 (3F)

Chairperson : Kwang-Won Kim (Gachon University, Korea), Tae Sun Park (Jeonbuk National University)

	12:40-12:55	How to find optimal combination therapy for patients with type 2 diabetes Seung Jin Han (Ajou University, Korea)
	12:55-13:10	Cutting edge care of pitavastatin with ezetimibe combination therapy Seung-Hwan Lee (The Catholic University of Korea, Korea)

Luncheon symposium 6 [Bukwang Pharmaceutical] & [Hanmi Pharmaceutical] Day 3, Saturday, October 28, 12:40-13:10 / Room 3 (3F)

Chairpersons : Bong-Soo Cha (Yonsei University, Korea), Bon Jeong Ku (Chungnam National University, Korea)

	12:40-12:55	Treatment strategies for diabetic peripheral neuropathy based on its pathogenesis Chong Hwa Kim (Sejong General Hospital, Korea)
	12:55-13:10	A paradigm shift in dyslipidemia treatment Sung Hoon Yu (Hanyang University, Korea)

Scientific program